Christopher Roberts
Direttore Finanziario/CFO presso AC IMMUNE SA
Patrimonio netto: 28 856 $ in data 30/04/2024
Provenienza dei contatti di primo grado di Christopher Roberts
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
27
| Public Company | Pharmaceuticals: Major | 27 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Christopher Roberts tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| University of Lausanne | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member Director/Board Member | |
| École Polytechnique Fédérale de Lausanne | College/University | Graduate Degree Doctorate Degree | |
Inventages II
 Inventages II Investment ManagersFinance Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements. | Investment Managers | Founder Founder | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Graduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Milan | College/University | Doctorate Degree | |
Dimerix Bioscience Pty Ltd.
 Dimerix Bioscience Pty Ltd. Medical DistributorsDistribution Services Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia. | Medical Distributors | Chief Executive Officer | |
| University of Bern | College/University | Undergraduate Degree | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of St. Gallen | College/University | Corporate Officer/Principal | |
| Swiss Institute for Empirical Economic Research | Director/Board Member | ||
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| DIMERIX LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| University of Zurich | College/University | Undergraduate Degree | |
| World Demographic & Ageing Forum | Corporate Officer/Principal | ||
| Center for Disability & Integration | Corporate Officer/Principal | ||
| CESifo Research Network | Corporate Officer/Principal | ||
| Network for Studies on Pensions Aging Retirement | Corporate Officer/Principal | ||
| Swiss Federal Commission for Economic Issues | Corporate Officer/Principal | ||
| SCHINDLER HOLDING AG | Industrial Machinery | Director/Board Member | |
| SCHWEIZERISCHE NATIONALBANK | Major Banks | Director/Board Member | |
| HUBER+SUHNER AG | Telecommunications Equipment | Director/Board Member | |
| Swiss Institute For Intl Economics & Applied Economic Research | Chairman | ||
| Swiss Society of Economics & Statistics | President | ||
| Richard Büchner Foundation | Director/Board Member | ||
| University of Tilburg | College/University | Corporate Officer/Principal | |
| Institute of Public Finance & Fiscal Law | Corporate Officer/Principal | ||
| Université Paris Dauphine-PSL | College/University | Graduate Degree | |
| BIOMÉRIEUX | Medical Specialties | Director of Finance/CFO | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| University of Vienna | College/University | Doctorate Degree | |
| EVOTEC SE | Pharmaceuticals: Major | Chief Executive Officer | |
Pantec Biosolutions AG
 Pantec Biosolutions AG Drugstore ChainsRetail Trade Pantec Biosolutions AG provides laser microporation based transdermal drug delivery services. Its technology can be used for transdermal delivery, intradermal delivary, epidermal delivery, infertility patches, and aesthetic dermatology. The company was founded by Christof Böhler, Herbert Zech, Reinhard Braun, Werner Braun, and Thomas Bragagna in 2006 and is headquartered in Ruggell, Liechtenstein. | Drugstore Chains | Director/Board Member | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
Topas Therapeutics GmbH
 Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | Pharmaceuticals: Major | Chairman | |
Federation of Austrian Industry
 Federation of Austrian Industry Miscellaneous Commercial ServicesCommercial Services The Federation of Austrian Industry is an organization that focuses on the observation and analysis of international developments, trade and investment agreements, and the conditions of fair international competition. The non-profit company is based in Vienna, Austria. Austria is a small but highly export-oriented economy, and the organization believes that for the future growth and prosperity of the country, its companies must have the best possible framework to take advantage of their international opportunities. The organization emphasizes the importance of sustainable international relationships and free and fair trade to ensure Austria's export capability and access to markets. The CEO of the Austrian company is Martin Ohneberg. | Miscellaneous Commercial Services | Director/Board Member | |
Evotec (UK) Ltd.
 Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991. | Miscellaneous Commercial Services | Director/Board Member | |
| NOVIMMUNE SA | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| Medical College of Virginia | College/University | Doctorate Degree | |
| Max Schmidheiny-Stiftung | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| Serono Pharmaceutical Research Institute | Corporate Officer/Principal | ||
| Glaxo-Welcomes' Research Institute | Corporate Officer/Principal | ||
| Basel Institute for Immunology | College/University | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Svizzera | 26 |
| Germania | 6 |
| Stati Uniti | 6 |
| Paesi Bassi | 4 |
| Francia | 4 |
Settori
| Consumer Services | 15 |
| Health Technology | 14 |
| Finance | 4 |
| Commercial Services | 3 |
| Distribution Services | 2 |
Posizioni
| Director/Board Member | 106 |
| Corporate Officer/Principal | 52 |
| Independent Dir/Board Member | 27 |
| Chairman | 25 |
| Chief Tech/Sci/R&D Officer | 21 |
Contatti più connessi
| Insiders | |
|---|---|
| Friedrich von Bohlen und Halbach | 36 |
| Alan Colowick | 30 |
| Douglas Williams | 25 |
| Monika Bütler | 25 |
| Martin Velasco | 15 |
| Werner Lanthaler | 12 |
| Andrea Pfeifer | 11 |
| Thomas Graney | 11 |
| Carl June | 9 |
| Gary Waanders | 8 |
| Monica Shaw | 8 |
| Marie Kosco-Vilbois | 7 |
| Sonia Maria Poli | 7 |
| Roy Ervin Twyman | 6 |
| Julien Rongère | 5 |
- Borsa valori
- Insiders
- Christopher Roberts
- Connessioni Società
